Type not reported
Lactose monohydrate 320mg tablet, once orally, for 2 study visits
Total Trials
1
Max Phase
-
Type
UNKNOWN
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Lactose monohydrate 320mg tablet, once orally, for 2 study visitsRegistry product
Linked study entry; product equivalence not established
Formulation reported by source: N/A
View study and source
Success Metrics
Active Trials
0(0%)
Phase Distribution
Phase 4
1
100%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Other(1)
Detailed Status
unknown1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
unknown1100%
Recent Activity
Clinical Trials (1)
Drug Details
- Intervention Type
- Type not reported
- Total Trials
- 1